J.P. Morgan Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $1,150

J.P. Morgan analyst Chris Schott maintains $Regeneron Pharmaceuticals(REGN.US)$ with a buy rating, and adjusts the target price from $1,050 to $1,150.According to TipRanks data, the analyst has a succ

moomoo NewsJun 18 20:31 ET · Ratings

Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?

Yahoo FinanceJun 18 13:22 ET

Regeneron Pharmaceuticals Hits All-time High

Trading EconomicsJun 18 10:18 ET

Regeneron Pharmaceuticals(REGN.US) Director Sells US$1.6 Million in Common Stock

$Regeneron Pharmaceuticals(REGN.US)$ Director BROWN MICHAEL S sold 1,535 shares of common stock on Jun 14, 2024 at an average price of $1,040 for a total value of $1.6 million.Source: Announcement Wha

moomoo NewsJun 17 16:44 ET

Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing

Michael S Brown, Director, on June 14, 2024, sold 1,535 shares in Regeneron Pharmaceuticals (REGN) for $1,596,400. Following the Form 4 filing with the SEC, Brown has control over a total of 12,544 sh

MT NewswiresJun 17 16:05 ET

New Weight-Loss Drugs and Devices Are Coming This Week

Weight-loss breakthroughs all emerged from diabetes treatment. Meetings such as the coming American Diabetes Association are increasingly dominated by news on obesity drugs.

BarronsJun 17 15:25 ET